Quanterix (QTRX) Change in Receivables (2017 - 2026)
Quanterix's (QTRX) quarterly Change in Receivables came in at -$2.7 million in Q1 2026, up 37.24% YoY from -$2.0 million in Q1 2025, and little changed on a QoQ basis from -$2.7 million in Q4 2025.
Quanterix (QTRX) Change in Receivables (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Change in Receivables data on file, last reported at -$2.7 million in Q1 2026.
- Quarterly Change in Receivables rose 37.24% year-over-year to -$2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.0 million (down 1091.66% YoY) and the FY2025 annual result came in at -$10.6 million, down 237.71% from the prior year.
- Change in Receivables steadied at -$2.7 million in Q1 2026, from -$2.7 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $4.1 million in Q1 2024 to a low of -$5.1 million in Q2 2025.
- A 5-year average of -$240176.5 and a median of -$135000.0 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables sank 543.53% — and 2023, when it surged 1072.97%.
- Tracing QTRX's Change in Receivables over 5 years: stood at -$111000.0 in 2022, then surged by 1072.97% to $1.1 million in 2023, then advanced by 20.56% to $1.3 million in 2024, then tumbled by 307.99% to -$2.7 million in 2025, then dropped by 0.33% to -$2.7 million in 2026.
- The last three Change in Receivables figures came in at -$2.7 million (Q1 2026), -$2.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Quanterix | 141.97 Mn | 48.44 Mn | 12.67 Mn | -4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.10 Mn |
| Jun 30, 2026 | -4.10 Mn |
| Mar 31, 2026 | -2.72 Mn |
| Mar 31, 2026 | -2.72 Mn |
| Dec 31, 2025 | -2.71 Mn |
| Dec 31, 2025 | -2.71 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | -5.15 Mn |
| Jun 30, 2025 | -5.15 Mn |
| Mar 31, 2025 | -4.33 Mn |
| Mar 31, 2025 | -4.33 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | -840,000.00 |
| Sep 30, 2024 | -840,000.00 |
| Jun 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Mar 31, 2024 | 4.13 Mn |